MENU
SGMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sagimet Biosciences (SGMT) Earnings Date & Reports

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways... Show more

A.I. Advisor
published Earnings

SGMT is expected to report earnings to rise 200.00% to -120 cents per share on March 30

Sagimet Biosciences SGMT Stock Earnings Reports
Q4'25
Est.
$-1.20
Q3'25
Beat
by $0.64
Q2'25
Beat
by $0.56
Q1'25
Beat
by $0.15
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -40 cents, beating the estimate of -103 cents. With 698.08K shares outstanding, the current market capitalization sits at 207.16M.
View a ticker or compare two or three
SGMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SGMT showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
155 Bovet Road
Phone
+1 650 561-8600
Employees
10
Web
https://www.sagimet.com